Jimin Shi

2.9k total citations · 1 hit paper
135 papers, 1.5k citations indexed

About

Jimin Shi is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Jimin Shi has authored 135 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Hematology, 37 papers in Oncology and 32 papers in Immunology. Recurrent topics in Jimin Shi's work include Hematopoietic Stem Cell Transplantation (61 papers), Acute Myeloid Leukemia Research (36 papers) and Acute Lymphoblastic Leukemia research (24 papers). Jimin Shi is often cited by papers focused on Hematopoietic Stem Cell Transplantation (61 papers), Acute Myeloid Leukemia Research (36 papers) and Acute Lymphoblastic Leukemia research (24 papers). Jimin Shi collaborates with scholars based in China, France and United Kingdom. Jimin Shi's co-authors include He Huang, Yi Luo, Yamin Tan, Yanmin Zhao, Xiaoyu Lai, Zhen Cai, Weiyan Zheng, Jingsong He, Jian Yu and Lizhen Liu and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Jimin Shi

118 papers receiving 1.5k citations

Hit Papers

Microplastics dampen the self-renewal of hematopoietic st... 2024 2026 2025 2024 10 20 30 40

Peers

Jimin Shi
Julie Rayes United Kingdom
Frances M. Gibson United Kingdom
Jimin Shi
Citations per year, relative to Jimin Shi Jimin Shi (= 1×) peers Hongsheng Zhou

Countries citing papers authored by Jimin Shi

Since Specialization
Citations

This map shows the geographic impact of Jimin Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jimin Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jimin Shi more than expected).

Fields of papers citing papers by Jimin Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jimin Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jimin Shi. The network helps show where Jimin Shi may publish in the future.

Co-authorship network of co-authors of Jimin Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Jimin Shi. A scholar is included among the top collaborators of Jimin Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jimin Shi. Jimin Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Ce, Xiangjun Zeng, Yi Luo, et al.. (2025). Machine learning-based prediction of G-CSF-induced hematopoietic stem cell mobilization outcomes in healthy volunteers. Bone Marrow Transplantation. 60(10). 1316–1324.
2.
Lai, Xiaoyu, Lizhen Liu, Panpan Zhu, et al.. (2025). KRAS mutation status critically determines the clinical outcome of patients with KMT2A‐rearranged acute myeloid leukemia. Cancer. 131(13). e35941–e35941.
4.
Zhu, Panpan, Jimin Shi, Lizhen Liu, et al.. (2024). Graft CD8 T‐cell‐based risk system predicts survival in antithymocyte globulin‐based myeloablative haploidentical peripheral blood stem cell transplantation. Clinical & Translational Immunology. 13(1). e1484–e1484.
5.
Jiang, Bingqian, Yanmin Zhao, Yi Luo, et al.. (2024). Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients With Acute Myeloid Leukemia Harboring KMT2A Rearrangement and Its Prognostic Factors. Cell Transplantation. 33. 4231283677–4231283677. 4 indexed citations
6.
Chen, Weihao, Jimin Shi, Yi Luo, et al.. (2024). Risk factors and long-term outcomes for human herpesvirus 6 encephalitis in the early period after allogeneic stem cell transplantation. Bone Marrow Transplantation. 59(10). 1387–1393. 2 indexed citations
7.
Zhu, Panpan, Xiaoyu Lai, Lizhen Liu, et al.. (2024). Impact of myelofibrosis on patients with myelodysplastic syndromes following allogeneic hematopoietic stem cell transplantation. Journal of Translational Medicine. 22(1). 275–275. 1 indexed citations
8.
Shao, Jie, Tingting Yang, Ye Zhao, et al.. (2024). T-Cell Posttransplant Lymphoproliferative Disorders After Allogeneic Hematopoietic Stem Cell Transplantation: Case Series and Systemic Review. Cell Transplantation. 33. 4241317578–4241317578.
9.
Jiang, Lingli, Yishan Ye, Yingli Han, et al.. (2024). Microplastics dampen the self-renewal of hematopoietic stem cells by disrupting the gut microbiota-hypoxanthine-Wnt axis. Cell Discovery. 10(1). 35–35. 42 indexed citations breakdown →
10.
Shi, Jimin, Xiaoyu Lai, Yanmin Zhao, et al.. (2023). Survival and late mortality among patients who survived disease‐free for 2 years after stem cell transplantation. British Journal of Haematology. 202(3). 608–622. 3 indexed citations
11.
Lai, Xiaoyu, Jimin Shi, Lizhen Liu, et al.. (2023). A novel risk model for predicting early relapse in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem-cell transplantation. Bone Marrow Transplantation. 58(7). 801–810. 2 indexed citations
13.
Liu, Lizhen, Xinyu Ji, Panpan Zhu, et al.. (2023). Double filtration plasmapheresis combined with rituximab for donor‐specific antibody desensitization in haploidentical haematopoietic stem cell transplantation. British Journal of Haematology. 203(5). 829–839. 4 indexed citations
14.
Liu, Yanru, Panpan Zhu, Jimin Shi, et al.. (2022). Impact of Donor-to-Recipient ABO Mismatch on Outcomes of Antithymocyte Globulin-Based Peripheral Blood Stem Cell-Derived Myeloablative Conditioning Haploidentical Stem Cell Transplantation. Transplantation and Cellular Therapy. 28(6). 331.e1–331.e10. 3 indexed citations
16.
Ye, Yishan, Florent Malard, Jimin Shi, et al.. (2021). Comparison of non-first-degree related donors and first-degree related donors in haploidentical HSCT: a multi-centre retrospective analysis. Bone Marrow Transplantation. 56(10). 2567–2574. 5 indexed citations
17.
Lai, Xiaoyu, Jimin Shi, Yamin Tan, et al.. (2021). Effect of donor characteristics on T cell‐replete haploidentical stem cell transplantation over the last 10 years at a single institution. British Journal of Haematology. 196(5). 1225–1238. 10 indexed citations
18.
Zhang, Mingming, Haowen Xiao, Jimin Shi, et al.. (2021). Improved survival for young acute leukemia patients following a new donor hierarchy for allogeneic hematopoietic stem cell transplantation: A phase III randomized controlled study. American Journal of Hematology. 96(11). 1429–1440. 1 indexed citations
19.
Tan, Yamin, Jimin Shi, Yanmin Zhao, et al.. (2020). Prophylactic modified donor lymphocyte infusion after low-dose ATG-F-based haploidentical HSCT with myeloablative conditioning in high-risk acute leukemia: a matched-pair analysis. Bone Marrow Transplantation. 56(3). 664–672. 11 indexed citations
20.
Luo, Yi, Haowen Xiao, Xiaoyu Lai, et al.. (2014). T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT. Blood. 124(17). 2735–2743. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026